News Owlstone's breath diagnostic to be used in asthma research Owlstone's ReCIVA and FAIMS technologies will be used to discover asthma-specific biomarkers.
News Owlstone's breath-based lung cancer diagnostic could save 10... Trial's next phase will recruit 3,000 patients across 21 international sites.
News Bill Anderson will replace Baumann as Bayer CEO Just weeks after Roche pharma chief Bill Anderson resigned to seek other opp
News Welcome to the new pharmaphorum Our website has served us well over the years, but after five years since the last re-design – during which aesthetic standards have changed and website technology has improved
